Biotech/Pharma Stocks To Watch In The First Days Of February

The final week of January was yet another big one for biotech, with perhaps the most important development of the week being phase III trial results for Novavax’s COVID-19 vaccine. For the first week of February, today’s article identifies some biotech/pharma stocks worth paying attention to on account of pending data readouts of COVID-19 trials — including for a potential oral COVID-19 vaccine — and FDA decisions. For more, CLICK HERE.